213 top medical experts on Tay-Sachs Disease across 24 countries and 16 U.S. states, including 43 MDs (Physicians). This is based on an objective analysis of their Scientific Publications, Clinical Trials, Medicare, and NIH Grants.

  1. Tay-Sachs Disease: An autosomal recessive neurodegenerative disorder characterized by the onset in infancy of an exaggerated startle response, followed by paralysis, dementia, and blindness. It is caused by mutation in the alpha subunit of the hexosaminidase A resulting in lipid-laden ganglion cells. It is also known as the B variant (with increased hexosaminidase B but absence of hexosaminidase A) and is strongly associated with Ashkenazic Jewish ancestry.
  2. Clinical guidelines are the recommended starting point to understand initial steps and current protocols in any disease or procedure:
  3. Broader Categories (#Experts): GM2 Gangliosidoses (357).
  4. Clinical Trials ClinicalTrials.gov : at least 23 including 3 Active, 9 Completed, 8 Recruiting
  5. Synonyms: Type I G(M2) Gangliosidosis,  Type I Gangliosidosis G(M2),  B Variant Gangliosidosis GM2,  Hexosaminidase A Deficiency Disease,  B Variant Tay-Sachs Disease


  

        

                    


    Computing Expert Listing ...

);